Cargando…
Cardiac involvement in MPS patients: incidence and response to therapy in an Italian multicentre study
BACKGROUND: Mucopolysaccharidoses (MPSs) are a group of lysosomal storage disorders caused by the deficit of lysosomal hydrolases involved in the degradation of glycosaminoglycans (GAGs). The course is chronic and progressive, with multisystemic involvement that often leads to cardiovascular disease...
Autores principales: | Sestito, Simona, Rinninella, Giada, Rampazzo, Angelica, D’Avanzo, Francesca, Zampini, Lucia, Santoro, Lucia, Gabrielli, Orazio, Fiumara, Agata, Barone, Rita, Volpi, Nicola, Scarpa, Maurizio, Tomanin, Rosella, Concolino, Daniela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245260/ https://www.ncbi.nlm.nih.gov/pubmed/35768874 http://dx.doi.org/10.1186/s13023-022-02396-5 |
Ejemplares similares
-
Molecular diagnosis of patients affected by mucopolysaccharidosis: a multicenter study
por: Zanetti, Alessandra, et al.
Publicado: (2019) -
Clinical efficacy of Enzyme Replacement Therapy in paediatric Hunter patients, an independent study of 3.5 years
por: Tomanin, Rosella, et al.
Publicado: (2014) -
Mucopolysaccharidoses Differential Diagnosis by Mass Spectrometry-Based Analysis of Urine Free Glycosaminoglycans—A Diagnostic Prediction Model
por: D’Avanzo, Francesca, et al.
Publicado: (2023) -
Glycosaminoglycan signatures in body fluids of mucopolysaccharidosis type II mouse model under long-term enzyme replacement therapy
por: Maccari, Francesca, et al.
Publicado: (2022) -
Mucopolysaccharidosis Type II: One Hundred Years of Research, Diagnosis, and Treatment
por: D’Avanzo, Francesca, et al.
Publicado: (2020)